Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1

• Antonia Janssen,

  Affiliations Institute for Medical Immunology, Charité—Universitätmedizin Berlin, Berlin, Germany, Experimental and Clinical Research Center, joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany

  ⨯
• Sebastian Fiebiger,

  Affiliations Institute for Medical Immunology, Charité—Universitätmedizin Berlin, Berlin, Germany, Experimental and Clinical Research Center, joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany

  ⨯
• Helena Bros,

  Affiliations Institute for Medical Immunology, Charité—Universitätmedizin Berlin, Berlin, Germany, Experimental and Clinical Research Center, joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany, NeuroCure Clinical Research Center, Charité—Universitätmedizin Berlin, Berlin, Germany

  ⨯
• Laura Hertwig,

  Affiliations Institute for Medical Immunology, Charité—Universitätmedizin Berlin, Berlin, Germany, Experimental and Clinical Research Center, joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany

  ⨯
• Silvina Romero-Suarez,

  Affiliations Institute for Medical Immunology, Charité—Universitätmedizin Berlin, Berlin, Germany, Experimental and Clinical Research Center, joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany

  ⨯
• Isabell Hamann,

  Affiliations Institute for Medical Immunology, Charité—Universitätmedizin Berlin, Berlin, Germany, Experimental and Clinical Research Center, joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany

  ⨯
• Coralie Chanvillard,

  Affiliations Institute for Medical Immunology, Charité—Universitätmedizin Berlin, Berlin, Germany, Experimental and Clinical Research Center, joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany

  ⨯
• Judith Bellmann-Strobl,

  Affiliations Experimental and Clinical Research Center, joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany, NeuroCure Clinical Research Center, Charité—Universitätmedizin Berlin, Berlin, Germany, Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Friedemann Paul,

  Affiliations Experimental and Clinical Research Center, joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany, NeuroCure Clinical Research Center, Charité—Universitätmedizin Berlin, Berlin, Germany, Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Jason M. Millward,

  Affiliations Institute for Medical Immunology, Charité—Universitätmedizin Berlin, Berlin, Germany, Experimental and Clinical Research Center, joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany

  ⨯
• Carmen Infante-Duarte

  * E-mail: carmen.infante@charite.de

  Affiliations Institute for Medical Immunology, Charité—Universitätmedizin Berlin, Berlin, Germany, Experimental and Clinical Research Center, joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany

  ⨯